StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

BioAdaptives's operating cash flow for the twelve months ending Jun 30, 2026 was -$436.36K. For fiscal 2025 it was -$516.03K. The highest annual figure on record is -$72 in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$516.03K–
FY2024Dec 31, 2024-$249.52K–
FY2023Dec 31, 2023-$223.77K–
FY2022Dec 31, 2022-$227.26K–
FY2021Dec 31, 2021-$158.65K–
FY2020Dec 31, 2020-$106.89K–
FY2019Dec 31, 2019-$168.12K–
FY2018Dec 31, 2018-$420.15K–
FY2015Dec 31, 2015-$72–
FY2014Dec 31, 2014-$58.63K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$44.39K–
Q1 FY2026Mar 31, 2026-$84.84K–
Q4 FY2025Dec 31, 2025-$155.83K–
Q3 FY2025Sep 30, 2025-$151.31K–
Q2 FY2025Jun 30, 2025-$110.98K–
Q1 FY2025Mar 31, 2025-$97.91K–
Q4 FY2024Dec 31, 2024-$100.54K–
Q3 FY2024Sep 30, 2024-$56.34K–
Q2 FY2024Jun 30, 2024-$51.46K–
Q1 FY2024Mar 31, 2024-$41.18K–
Q4 FY2023Dec 31, 2023-$91.30K–
Q3 FY2023Sep 30, 2023-$56.15K–
Q2 FY2023Jun 30, 2023-$56.87K–
Q1 FY2023Mar 31, 2023-$19.46K–
Q4 FY2022Dec 31, 2022-$27.50K–
Q3 FY2022Sep 30, 2022-$61.54K–
Q2 FY2022Jun 30, 2022-$77.06K–
Q1 FY2022Mar 31, 2022-$61.16K–
Q4 FY2021Dec 31, 2021-$35.40K–
Q3 FY2021Sep 30, 2021-$33.17K–
Q2 FY2021Jun 30, 2021-$29.71K–
Q1 FY2021Mar 31, 2021-$60.36K–
Q4 FY2020Dec 31, 2020-$9.86K–
Q3 FY2020Sep 30, 2020-$34.48K–
Q2 FY2020Jun 30, 2020-$20.23K–
Q1 FY2020Mar 31, 2020-$42.31K–
Q4 FY2019Dec 31, 2019-$76.40K-747.0%
Q3 FY2019Sep 30, 2019-$32.37K–
Q2 FY2019Jun 30, 2019-$12.45K–
Q1 FY2019Mar 31, 2019-$46.90K-5104.9%
Q3 FY2016Sep 30, 2016$11.81K+7772.7%
Q2 FY2016Jun 30, 2016-$209–
Q1 FY2016Mar 31, 2016-$1.71K–
Q4 FY2015Dec 31, 2015$937–
Q3 FY2015Sep 30, 2015$150–

More BioAdaptives figures

See a number that looks wrong?